OLUWATOYIN ALUKO: Open Payments
NPI 1659952984 · MANSFIELD, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$371 in 19 payments from 5 companies in 2025. Trend: 2023 $527 · 2024 $139 · 2025 $371
Food & beverage: $371
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $264 |
| Janssen Pharmaceuticals, Inc | 2 | $41 |
| Lundbeck LLC | 1 | $27 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
Products named: CAPLYTA, SPRAVATO, REXULTI, FANAPT, Qelbree.
Industry payments across TX — which companies pay providers there.
